Clinical Trials Logo
  1. Home
  2. Brugada Syndrome
  3. NCT04808193
  4. Details
NCT04808193 Clinical Trial

European Perioperative Brugada Survey

Brugada Syndrome Clinical Trial

Official title:
European Perioperative Brugada Survey

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT04808193
Other study ID # EUPerBrugadaSurvey
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 31, 2021
Est. completion date December 31, 2021

Study information
Verified date March 2021
Source Universitair Ziekenhuis Brussel
Contact Evelien Vandeurzen
Phone 192 92 37
Email evelien.vandeurzen@uzbrussel.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this survey is to assess the current perception and clinical practice of Resident and Board-certified Anaesthesiologists and Intensivists regarding perioperative care of patients burdened with the Brugada Syndrome. It is intended to investigate this primarily on national and secondarily on European level.

Recruitment information / eligibility
Status Recruiting
Enrollment 300
Est. completion date December 31, 2021
Est. primary completion date December 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - All participants must have received an invitation to participate in the survey through the online platform of the European Society of Anaesthesiology and Intensive Care. Exclusion Criteria: - Uninvited participation in the survey is not possible.

Study Design

Related Conditions & MeSH terms

Intervention

Other:
• Survey
Participants will fill in the survey

Locations
Country Name City State
Belgium UZ Brussel Jette Brussel

Sponsors (1)
Lead Sponsor Collaborator
Universitair Ziekenhuis Brussel

Country where clinical trial is conducted

Belgium, 

Outcome
Type Measure Description Time frame Safety issue
Primary Questionnaire about treatments for Brugada patients Number of participants with treatment-related information as assessed by the survey/questionnaire N/A 1 hour
See also
  Status Clinical Trial Phase
Recruiting NCT05048602 - Drug-induced Brugada Syndrome Research Database
Terminated NCT00701077 - DAPERB 3,4-DiAminoPyridine and Electrophysiological Response in Brugada Syndrome Phase 3
Recruiting NCT03435393 - Ripple Mapping for Epicardial Mapping of Brugada Syndrome N/A
Active, not recruiting NCT02933437 - The Response To Ajmaline Provocation in Healthy Subjects Phase 2
Active, not recruiting NCT04257994 - Distribution of Cell-cell Junction Proteins in Arrhythmic Disorders
Recruiting NCT05685134 - Invasive and Clinical Features in Patients With Brugada Syndrome Undergoing Catheter Ablation N/A
Recruiting NCT04580992 - Defining the Electrocardiographic Effect of Propofol on the Ajmaline Provocation Drug Challenge: A Prospective Trial
Completed NCT02641431 - Epicardial Ablation in Brugada Syndrome N/A
Completed NCT03182777 - Safety of Local Dental Anesthesia in Patients With Cardiac Channelopathies N/A
Completed NCT00292032 - Registry of Unexplained Cardiac Arrest
Completed NCT04124237 - Long Term Monitoring for Risk of Sudden Death
Completed NCT02344277 - Evaluation of Subcutaneous Implantable Cardiac Defibrillator in Brugada Patients
Completed NCT04650009 - Physical Activity in Children With Inherited Cardiac Diseases
Recruiting NCT03491475 - Echocardiography During Ajmaline Test
Recruiting NCT05521451 - Clinical Cohort Study - TRUST
Recruiting NCT03485508 - The Brugada Syndrome: a Follow-up Study
Completed NCT00702117 - Ajmaline Utilization in the Diagnosis and Treatment of Cardiac Arrhythmias Phase 4
Recruiting NCT02704416 - Ablation in Brugada Syndrome for the Prevention of VF N/A
Recruiting NCT03775954 - Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
Completed NCT04420078 - Brugada Ablation of VF Substrate Ongoing MultiCenter Registry